INVITE (IN 30 MIN): Guggenheim Grand Rounds - Dr. Lieberman's Take on Today's NGN-401 Ph 1/2 Data in Rett Syndrome

研报英文原文证据摘录

INVITE (IN 30 MIN): Guggenheim Grand Rounds - Dr. Lieberman's Take on Today's NGN-401 Ph 1/2 Data in Rett Syndrome

BIOTECHNOLOGY

June 29, 2026

DISCLAIMER

Important Notices and Disclosures Please forward the language below to your Compliance team: Guggenheim Securities, LLC is providing

notice to you and your firm’s Compliance department that we have invited personnel from your firm to attend the above-referenced event.

Attendees are advised that any information or materials discussed at the event or provided in connection therewith (the “materials”) are

provided for informational and educational purposes only and should not be considered a recommendation of any particular security,

strategy or investment product, as investing advice of any kind, or as offering or providing any investment product or service, or as an offer

or solicitation with respect to the purchase or sale of any investment by Guggenheim Securities, LLC or any of its affiliates (“Guggenheim”).

The materials are not provided in an advisory or fiduciary capacity and may not be relied upon for or in connection with the making of

investment decisions. The views expressed during the event and/or in the materials are solely those of the authors, participants, investment

bankers and other presenters (collectively, the “Presenters”) and may differ from the views of other officers, directors, employees or other

representatives (as to any person or entity, its “Representatives”) of Guggenheim or any other Presenter. The Presenters’ opinions are

subject to change without notice. Neither Guggenheim nor any other Presenter undertakes any obligation to provide additional information

or any update to or correction of the information discussed or provided at the event or otherwise in connection therewith. Sources for